Literature DB >> 20149339

Incidence, ocular manifestations, and survival in children with neuroblastoma: a population-based study.

Stephen J Smith1, Nancy N Diehl, Brian D Smith, Brian G Mohney.   

Abstract

PURPOSE: To determine the incidence, ophthalmic manifestations, and survival among children with neuroblastoma in a defined population.
DESIGN: Population-based retrospective cohort.
METHODS: The medical records of all pediatric (<19 years) residents of Olmsted County, Minnesota, diagnosed with neuroblastoma from January 1, 1969, through December 31, 2008, were retrospectively reviewed.
RESULTS: Fourteen children were diagnosed with neuroblastoma as residents of Olmstead County, Minnesota, during the 40-year period, yielding an age- and gender-adjusted incidence of 11.8 (95% confidence interval [CI]: 5.6-18.0) per million patients <15 years of age. The calculated incidence for patients presenting before the age of 5 in this cohort was 1 in 5970 children (95% CI: 3920-12 580 children). The mean age at diagnosis for the 14 study patients was 22.5 months (range, 10.4-42.6 months). Six of the 14 (43%; 95% CI: 18%-71%) had ocular manifestations, including orbital metastasis in 6 (100%), proptosis and ecchymosis in 4 (67%), ptosis in 2 (33%), and strabismus in 1 (17%). The Kaplan-Meier rate of survival for all 14 children was 57% at 1 year (95% CI: 36%-90%) and 50% at 5 years (95% CI: 30%-84%), while the 6 with eye findings had a survival rate of 17% at 9 months (95% CI: 3%-100%).
CONCLUSIONS: The incidence of neuroblastoma in this population was 11.8 per million patients <15 years, with ophthalmic involvement observed in 6 of the 14 study patients (43%). Orbital metastasis in the 6 children in this cohort was associated with poor prognosis. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20149339      PMCID: PMC3905802          DOI: 10.1016/j.ajo.2009.11.027

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  29 in total

1.  Heterochromia and Horner syndrome associated with cervical and mediastinal neuroblastoma.

Authors:  N Jaffe; R Cassady; R Petersen; D Traggis
Journal:  J Pediatr       Date:  1975-07       Impact factor: 4.406

2.  Horner's syndrome in childhood.

Authors:  C Sauer; M W Levingohn
Journal:  Neurology       Date:  1976-03       Impact factor: 9.910

3.  Ophthalmological aspects of neuroblastomatosis: a study of 53 verified cases.

Authors:  J E Alfano
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1968 Nov-Dec

4.  Eye signs in neuroblastoma.

Authors:  J Blake; C Fitzpatrick
Journal:  Trans Ophthalmol Soc U K       Date:  1972

5.  Statistical estimation of prognosis for children with neuroblastoma.

Authors:  N Breslow; B McCann
Journal:  Cancer Res       Date:  1971-12       Impact factor: 12.701

6.  Metastatic neuroblastoma causing bilateral blindness.

Authors:  E E Shubert; G L Oliver; N T Jaco
Journal:  Can J Ophthalmol       Date:  1969-01       Impact factor: 1.882

7.  Pediatric Horner syndrome.

Authors:  A R Jeffery; F J Ellis; M X Repka; J R Buncic
Journal:  J AAPOS       Date:  1998-06       Impact factor: 1.220

8.  Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification.

Authors:  Michio Kaneko; Yoshiaki Tsuchida; Hideo Mugishima; Naomi Ohnuma; Keiko Yamamoto; Keisei Kawa; Makoto Iwafuchi; Tadashi Sawada; Sachiyo Suita
Journal:  J Pediatr Hematol Oncol       Date:  2002-11       Impact factor: 1.289

9.  Screening of infants and mortality due to neuroblastoma.

Authors:  William G Woods; Ru-Nie Gao; Jonathan J Shuster; Leslie L Robison; Mark Bernstein; Sheila Weitzman; Greta Bunin; Isra Levy; Josee Brossard; Geoffrey Dougherty; Mendel Tuchman; Bernard Lemieux
Journal:  N Engl J Med       Date:  2002-04-04       Impact factor: 91.245

10.  Horner's syndrome: a retrospective analysis of 90 cases and recommendations for clinical handling.

Authors:  H Wilhelm; H Ochsner; E Kopycziok; S Trauzettel-Klosinski; U Schiefer; E Zrenner
Journal:  Ger J Ophthalmol       Date:  1992
View more
  8 in total

1.  Urine catecholamine levels as diagnostic markers for neuroblastoma in a defined population: implications for ophthalmic practice.

Authors:  S J Smith; N N Diehl; B D Smith; B G Mohney
Journal:  Eye (Lond)       Date:  2010-09-24       Impact factor: 3.775

2.  'Raccoon eyes' revisited.

Authors:  Luana A Stanescu; Marguerite T Parisi
Journal:  Pediatr Radiol       Date:  2010-10-13

3.  LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis.

Authors:  Shizhen Zhu; Xiaoling Zhang; Nina Weichert-Leahey; Zhiwei Dong; Cheng Zhang; Gonzalo Lopez; Ting Tao; Shuning He; Andrew C Wood; Derek Oldridge; Choong Yong Ung; Janine H van Ree; Amish Khan; Brittany M Salazar; Edroaldo Lummertz da Rocha; Mark W Zimmerman; Feng Guo; Hong Cao; Xiaonan Hou; S John Weroha; Antonio R Perez-Atayde; Donna S Neuberg; Alexander Meves; Mark A McNiven; Jan M van Deursen; Hu Li; John M Maris; A Thomas Look
Journal:  Cancer Cell       Date:  2017-08-31       Impact factor: 31.743

4.  LIN28B regulates transcription and potentiates MYCN-induced neuroblastoma through binding to ZNF143 at target gene promotors.

Authors:  Ting Tao; Hui Shi; Luca Mariani; Brian J Abraham; Adam D Durbin; Mark W Zimmerman; John T Powers; Pavlos Missios; Kenneth N Ross; Antonio R Perez-Atayde; Martha L Bulyk; Richard A Young; George Q Daley; A Thomas Look
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-29       Impact factor: 11.205

5.  Neuroblastoma Soft Tissue Metastasis in a 10-Month-Old Infant with a Right Thigh Mass.

Authors:  Shokouh Taghipour Zahir; Fateme Salemi
Journal:  Case Rep Med       Date:  2021-09-01

6.  Rapidly Progressive Ocular Proptosis as the First Sign of Neuroblastoma in a 16-Month-Old Child: Case Report and Review of Literature.

Authors:  Rahaf A Mandura
Journal:  Cureus       Date:  2022-01-06

Review 7.  Orbital neuroblastoma metastasis: A case report and literature review.

Authors:  Wan-Ju Yang; Yuan-Yuan Zhou; Fang Zhao; Zhong-Ming Mei; Shuang Li; Yi Xiang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

8.  Incidence of Horner syndrome associated with neuroblastic disease.

Authors:  Katarzyna Kuchalska; Monika Barełkowska; Katarzyna Derwich; Katarzyna Jończyk-Potoczna; Anna Gotz-Więckowska
Journal:  Childs Nerv Syst       Date:  2020-11-10       Impact factor: 1.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.